Bifenylo-4-amina. Dokumentacja proponowanych wartości dopuszczalnych poziomów narażenia zawodowego

• Autorzy: Starek A.

Warianty tytułu

EN

4-Aminobiphenyl

• Języki publikacji: PL

Abstrakty

PL

Bifenylo-4-amina (BA) jest substancją stałą, występującą w postaci wolnej aminy lub soli amoniowych z kwasami nieorganicznymi. Pierwsza postać rozpuszcza się w rozpuszczalnikach organicznych, podczas gdy druga w wodzie. Związek może występować także jako zanieczyszczenie aniliny oraz innych amin aromatycznych i ich pochodnych.BA stosowano jako antyutleniacz w przemyśle gumowym oraz jako półprodukt do syntezy barwników azowych. BA wykazuje słabą toksyczność ostrą i przewlekłą, ma działanie mutagenne po aktywacji metabolicznej oraz indukuje nowotwory, głównie raka pęcherza moczowego, u ludzi i zwierząt. Związek został zaliczony do grupy 1., tj. do czynników rakotwórczych dla ludzi, zgodnie z kryteriami IARC.W celu ustalenia wartości NDS bifenylo-4-aminy zastosowano metodę obliczeniową, opartą na przeliczeniu potencjału rakotwórczego związku obserwowanego u myszy na taki sam potencjał u człowieka. Na podstawie dawki BA wchłoniętej przez mysz i obserwowanego efektu kancerogennego, obliczono ekwiwalentną dawkę dla człowieka, przy założeniu, że ryzyko choroby nowotworowej wynosi lO-3. Następnie wchłoniętą dawkę tego związku przeliczono na jego stężenie w powietrzu środowiska pracy.Zaproponowano przyjęcie wartości NDS na poziomie 0,001 mg/m3 jako średnie stężenie ważone 8-godzinnym dniem pracy.

EN

4-Aminobiphenyl (BA) (CAS Registry No. 92-67-1) is a solid substance. It is used in rubber industry as an antioxidant and in synthesis of azo dye. BA is relatively low toxic but it is highly genotoxic and carcinogenic. The oral LD50 values for this compound in rodents range from 205 to 500 mg/kg b.w. BA and its metabolite IV-hydroxy-4-aminobiphenyl demonstrate the ability to induce gene mutations, usually in bacterial tests. This and other metabolites produce adducts with DNA and RNA of bladder epithelial cells. Carcinogenic potential of BA has been evidenced in some animal species and human beings. The compound induces bladder tumours. The proposed maximum exposure limit MAC (TWA) - 0.001 mg/m3 was calculate on the basis of slope factor (SF = 21 mg/kg/day) and accepted risk at 10m3.

Słowa kluczowe

PL

bifenylo-4-amina; działanie rakotwórcze; wartość NDS; narażenie zawodowe

EN

4-aminobiphenyl; MAC-values; carcinogenicity; occupational exposure

• Wydawca: Centralny Instytut Ochrony Pracy - Państwowy Instytut Badawczy
• Czasopismo: Podstawy i Metody Oceny Środowiska Pracy
• Rocznik: 2002
• Tom: Nr 1 (31)
• Strony: 5--23
• Opis fizyczny: Bibliogr. 78 poz., rys., tab.

Twórcy

autor

Starek A.

• STAREK Collegium Medicum Uniwersytetu Jagiellońskiego 30-688 Kraków ul. 30-688 Kraków ul. Medyczna 9

Bibliografia

• 1. Bayraktar N. i in. (1987) The oxidation of isomeric amino and acetamidobiphenyls by rat hepatic microsomal preparations. Arch. Toxicol. 60, 91-92.
• 2. Block N.L. i in. (1978) The initiation, progress, and diagnosis of dog bladder cancer induced by 4- aminobiphenyl. Invest. Urol. 16, 50-54.
• 3. Bonser G.M. i in. (1956) A further study of the carcinogenic properties of ortho-hydroxyamines and related compounds by bladder implantation in the mouse. Br. J. Cancer 10, 539-546.
• 4. Bos R.P. i in. (1982) Comparison of the mutagenicities of 4-aminobiphenyl and benzidine in the Sal- monella/microsome, Salmonella/hepatocyte and host-mediated assays. Mutation Res. 93, 317-325.
• 5. Cartwright R.A., Gleshan R.W., Rogers H.J. (1982) Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 1, 842-845.
• 6. Clayson D.B. i in. (1965) Correlation between the chemical induction of hyperplasia and of malignancy in the bladder epithelium. Br. J. Cancer 19, 297-310.
• 7. Clayson D.B., Lawson T.A., Pringle J.A.S. (1967) The carcinogenic action of 2-amino diphenylene oxide and 4-aminodiphenyl on the bladder and liver of C57XIF mouse. Br. J. Cancer 21, 755-762.
• 8. CND (1987) Cahiers des Notes Documentaires 129, 589.
• 9. Coghlin J.C. i in. (1991) 4-Aminobiphenyl hemoglobin adducts in fetuses to the tobacco smoke carcinogen in utero. J. Natl. Cancer Inst. 83, 274-280.
• 10. Czerczak S. i in. (1994) Krótka charakterystyka modeli matematycznych stosowanych w ilościowej ocenie ryzyka odpowiadającego dawkom w zakresie subeksperymentalnym. Medycyna Pracy 45, supl. 2, 49-53.
• 11. Deichman W.B. i in. (1956) The carcinogenic action of p-aminobiphenyl in dog. AMA Arch. Ind. Health 13, 8-12.
• 12. Deichman W.B. i in. (1958) The carcinogenic action of p-aminobiphenyl in dog. Ind. Med. Surg. 27, 25-26.
• 13. Deichman W.B. i in. (1965) Synergism among oral carcinogens. III. Simultaneous feeding of four bladder carcinogens to dogs. Ind. Med. Surg. 34, 640-649.
• 14. Deichman W.B., Mac Donald W.E. (1968) The non-carcinogenicity of a single dose of 4- aminobiphenyl in the dog. Food Cosmet. Toxicol. 6, 143-146.
• 15. Duverger-van Bogaert M.} Crutzen-Fayt M.C., Stecca C. (1991) Activation of some aromatic amines to mutagenic products by human red blood cell cytosol. Mutation Res. 263, 249-255.
• 16. Fourage M., Mercier M., Poncelet F. (1982) Mutagenicity of three aromatic amines in the presence of fractions from various tissues. Toxicol. Lett. 11, 313-320.
• 17. Frederickson S.M. i in. (1992) Acetyl transferase-mediated metabolic activation of AMiydroxy-4- aminobiphenyl by human uroepithelial cells. Carcinogenesis 13, 955-961.
• 18. Głowiński I.B., Radtke H.E., Weber W.W. (1978) Genetic variation in iV-acetylation of carcinogenic arylamines by human and rabbit liver. Mol. Pharmacol. 14, 940-949.
• 19. Głowiński I.B., Weber W.W. (1982) Genetic regulation of aromatic amine N-acetylation in inbred mice. J. Bol. Chem. 257, 1424-1430.
• 20. Gorrod J.W., Carter R.L., Roe F.J.C. (1968) Induction of hepatomas by 4-aminobiphenyl and three of its hydrohylated derivatives administered to newborn mice. J. Natl. Cancer Inst. 41, 403-410.
• 21. Green M.D., Tephly T.R. (1987) N-Glucuronidation of carcinogenic aromatic amines catalyzed by rat hepatic microsomal preparations and purified rat liver uridine 5'-diphosphate- glucuronosyltransferases. Cancer Res. 47, 2028-2031.
• 22. Hanke J., Lutz W., Jeromin L. (1994) Wykrywanie raka pęcherza moczowego metodami laboratoryjnymi oraz badaniem cytoskopowym. Łódź, Instytut Medycyny Pracy.
• 23. Hein D.W. i in. (1991) Extrahepatic expression of the iV-acetylation polymorphism toward arylamine carcinogens in tumor target organs of an inbred rat model. J. Pharmacol. Exp. Ther. 258, 232-236.
• 24.mHuang S.L., Waters M.D. (1983) Two methods to induce 6-thioguanine resistance in human fibroblasts in the presence of rat-liver microsomes. Mutation Res. 121, 71-76.
• 25. IARC (1972) Monographs on the evaluation of carcinogenic risks of chemicals to humans. Vol. 1. Some inorganic substances, chlorinated hydrocarbons, aromatic amines, Af-nitroso compounds and natural products. Lyon.
• 26.mIARC (1978) Vol. 16. Some aromatic amines and related nitro compounds - hair dyes, colouring agents, and miscellaneous industrial chemicals. Lyon.
• 27. IARC (1982) Vol. 28. The rubber industry. Lyon.
• 28. IARC (1986) Vol. 38.Tabacco smoking. Lyon.
• 29. IARC (1987) 4-Aminobiphenyl. Suppl. 7. Lyon.
• 30. ELO (1980) Occupational exposure limits for airborne toxic substances. Geneva.
• 31. Jakovljevic I.M., Zynger Bishara R.D. (1975) Thin layer chromatographic separation and fluoro- metric determination of 4-aminobiphenyl in 2-aminobiphenyl. Anal. Chem. 47, 2045-2046.
• 32. Jatoe S.D., Gorrod J.W. (1987) The in vitro/in vivo comparative metabolism of 4-aminobiphenyl using isolated hepatocytes. Toxicology 60, 65-68.
• 33. Karreth S., Lenk W. (1991a) The metabolism of 4-aminobiphenyl in rat. I. Reaction of iV-hydoxy-4- aminobiphenyl with rat blood in vivo. Xenobiotica 21, 709-724.
• 34. Karreth S., Lenk W. (1991b) The metabolism of 4-aminobiphenyl in rat. III. Urinary metabolites of 4- aminobiphenyl. Xenobiotica 21, 417-428.
• 35. Karreth S., Lenk W. (1991c) The metabolism of 4-aminobiphenyl in rat. IV. Ferrihaemoglobin forma¬tion by 4-aminobiphenyl metabolites. Xenobiotica 21, 971-977.
• 36. Kellermann G., Luyten-Kellermann M., Shaw CR. (1973) Genetic variations of aryl hydrocarbon hy¬droxylase in human lymphocytes. Am. J. Hum. Genet. 25, 327-335.
• 37. Kerdar R.S., Dehner D.y Wild D. (1993) Reactivity and genotoxicity of arylnitrenium ions in bacterial and mammalian cells. Toxicol., Lett. 67, 73-85.
• 38. King C.M., Głowiński J.B. (1983) Acetylation, deacetylation and acyltransfer. Environ. Health Persp. 49, 43-50.
• 39. King C.M. i in. (1976) Comparative adduct formation of 4-aminobiphenyl and 2-amino-fluorene de¬rivatives with macromolecules of isolated liver parenchymal cells. Cancer Res. 36, 2374-2381.
• 40. Koss L.G. i in. (1965) Carcinogenesis in the human urinary bladder. New Engl. J. Med. 272, 767-770.
• 41. Koss L.G., Melamed M.R., Kelly R.E. (1969) Further cytologic and histologic studies of bladder lesions in workers exposed to para-aminodiphenyl; progress report. J. Natl. Cancer Inst. 43, 233-243.
• 42. La Voie E.J. i in. (1989) On the maternal transfer of 4-aminobiphenyl in rats. Carcinogenesis 10, 231- 236.
• 43. Lower G.M. Jr., Bryan G.T. (1973) Enzymatic N-acetylation of carcinogenic aromatic amines by liver cytosol of species displaying different organ susceptibilities. Biochem. Pharmacol. 22, 1561-1588.
• 44. Lu L.J.W. i in. (1986) 32P-Postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo/a/pyrene. Cancer Res. 46, 3046-3054.
• 45. Lutz W., Sutkowski W. (1990) The oxidative phenotype as a marker of individual predisposition to neoplasm induced by chemical carcinogens. Pol. J. Occup. Med. 3, 257-272.
• 46. Manno M., loannides C., Gibson G.G. (1985) The modulation by arylamines of the in vitro formation of superoxide anion radicals and hydrogen peroxide by rat liver microsomes. Toxicol. Lett. 25, 121- 130.
• 47. Mastalerz P. (1986) Chemia organiczna. PWN, Warszawa.
• 48. Masson H.A. i in. (1983) The role of highly purified cytochrome P-450 isozymes in the activation of 4-aminobiphenyl to mutagenic products in the Ames test. Carcinogenesis 4, 1583-1586.
• 49. McMahon R.E., Turner J.C., Whitaker G. W. (1980) The N-hydroxylation and ring-hydroxylation of 4- aminobiphenyl in vitro by hepatic mono-oxygenases from rat, mouse, hamster, rabbit and guinea-pig. Xenobiotica 10, 469-481.
• 50. Melick W.F. i in. (1955) The first reported cases of human bladder tumors due to a new carcinogens - xenylamine. J. Urol. 74, 760-766.
• 51. Melick W.F., Naryka J.J., Kelly R.E. (1971) Bladder cancer due to exposure to para-aminobiphenyl: a 17-year followup. J. Urol. 106, 220-226.
• 52. Minchin R.F. i in. (1992) Direct O-acetylation of TV-hydroxy arylamines by acetylsalicylic acid to form carcinogen-DNA adducts. Carcinogenesis 13, 663-667.
• 53. Moriya M. i in. (1979) Assay for mutagenicity of bile in Sprague-Dawley rats treated subcutaneously with intestinal carcinogens. J. Natl. Cancer Inst. 63, 977-982.
• 54. Neal S.B., Probst G.S. (1983) Chemically-induced sister-chromatid exchanges in vivo in bone marrow of Chinese hamsters. Mutation Res. 113, 33-43.
• 55. Neis J.M. i in. (1984) Mutagenicity of benzidine and 4-aminobiphenyl after metabolic activation with isolated hepatocytes and liver 9000 x g supernatant from rat, hamster and guinea pig. Mutation Res. 129, 13-18.
• 56. Phillipson C.E., loannides C. (1983) Activation of aromatic amines to mutagens by various animal species including man. Mutation Res. 124, 325-336.
• 57. Poupko J.M., Radomski J.L., Hearn W.L. (1981) Bovine bladder mucosa microsomal cytochrome P- 450 and 4-aminobiphenyl N-hydroxylase activity. Cancer Res. 41, 1306-1310.
• 58. Probst G.S. i in. (1981) Chemically induced unscheduled DNA synthesis in primary rat hepatocyte cultures: a comparison with bacterial mutagenicity using 218 compounds. Environ. Mutagen. 3, 11-32.
• 59. Radomski J.L. i in. (1977) Isolation of the glucuronic acid conjugate of iV-hydroxy-4-aminobiphenyl from dog urine and its mutagenic activity. Cancer Res. 37, 1757-1762.
• 60. Radomski J.L., Rey A.A., Brill E. (1973) Evidence for a glucuronic acid conjugate of TV-hydroxy-4- aminobiphenyl in the urine of dogs given 4-aminobiphenyl. Cancer Res. 33, 1284-1289.
• 61. Sax N.I., Lewis R.J. (1989) Dangerous properties of industrial materials. 7th ed., vol. II. New York, Van Nostrand Reinhold, 446-447.
• 62. Schieferstein G.J. i in. (1985) Carcinogenesis of 4-aminobiphenyl in BALB/c- STCrlfC3Hf/N mice. Eur. J. Cancer Clin. Oncol. 21, 865-873.
• 63. Sheabar F.Z., Morningstar M.L., Wogan G.N. (1994) Adduct detection by acylation with (35S) methionine: Analysis of DNA adducts of 4-aminobiphenyl. Proc. Natl. Acad. Sci. USA, 91, 1696-1700.
• 64. Steele C.M., loannides C. (1986) Induction of rat hepatic mixed function oxidases by aromatic amines and its relationship to their bioactivation to mutagens. Mutation Res. 162, 41-46.
• 65. Swaminatham S., Frederickson S.M., Hatcher J.F. (1994) Metabolic activation of TV-hydroxy-4- acetylaminobiphenyl by cultured human breast epithelial cell line MCF lOA. Carcinogenesis 15, 611- 617.
• 66. Treli E., Korsagard R., Hood B. (1977) Aryl hydrocarbon hydroxylase inducibility in carcinoma of renal pelvis and ureter. Lancet 2, 612-613.
• 67. Tripathy N.K., Wiirgler F.E., Frei H. (1990) Genetic toxicity of six carcinogens and six noncarcinogens in the Drosophila wing spot test. Mutation Res. 242, 169-180.
• 68. Trzos R.J. i in. (1978) The evaluation of sixteen carcinogens in the rats using the micronucleus test. Mutation Res. 58, 79-86.
• 69. USDHHS (1988) U. S. Department of Health and Human Services. Public Health Service. Centers for Disease Control. Occupational safety and health guideline for 4-aminodiphenyl. Potential Human Carcinogen., 1-6.
• 70. Valencia R. i in. (1985) Chemical mutagenesis testing in Drosophila. III. Results of 48 coded compounds tested for the National Toxicology Program. Environ. Mutagen. 7, 325-348.
• 71. Veneis P. i in. (1994) Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 369, 154-156.
• 72. Walpole A.L., Williams M.H.C., Roberts D.C. (1954) Tumours of the urinary bladder in dogs after ingestion of 4-aminodiphenyl. Br. J. Ind. Med. 11, 105-109.
• 73. Weston A. i in. (1991) Measurement of 4-aminobiphenyl-hemoglobin adducts in lung cancer cases and controls. Cancer Res. 51, 5219-5223.
• 74. Yu M.C. i in. (1994) Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and asian men in Los Angeles. California. J. Natl. Cancer Inst. 86, 712- 716.
• 75. Ziegler D.M. i in. (1988) N-Methylation: potential mechanism for metabolic activation of carcinogenic primary arylamines. Proc. Natl. Acad. Sci. USA 85, 2514-2517.
• 76. RTECS (1982) Registry of toxic effects of chemical substances. DHHS (NIOSH) Publication No. 83- 107, Washington.
• 77. Rozporządzenie ministra zdrowia i opieki społecznej z dnia 1 lipca 1996 r. w sprawie wprowadzenia zakazu stosowania, obrotu i transportu niektórych niebezpiecznych substancji chemicznych. DzU nr 86, poz. 393.
• 78. Expedited cancer potency values and proposed regulatory levels for certain proposition 65 Carcinogens. California Environmental Protecion Agency (April 1992).